Provided for prescriber reference
GLP-1 analogues market size was exhibited at USD 18.61 billion in 2025 and is projected to be worth around USD 304.09 billion by 2035, growing at a CAGR of 32.23% from 2026 to 2036
The Australian Competition and Consumer Commission (ACCC) last month put the platforms on notice after it publicly announced it had written to them urging them to act on the ghost stores issue
GLP-1 receptor agonists reduce inflammatory cytokines, improve insulin resistance, aid gut health, and help lower the chronic inflammation that drives many forms of arthritis, as well as metabolic and heart diseases. Are GLP-1 medications safe, and who should not use them
These changes affect clothing fit dramatically, making fitted pants and shorts more comfortable and flattering
She is now a celebrity patient ambassador for the company